OUTLOOK THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 19.08 thousand shares for the 12-month period ending 2019-09-30, per its 10-K filed 2020-12-23.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2020-12-23
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-09-30 was 952.00 shares.
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-06-30 was 1.88K shares.
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-03-31 was 1.25K shares.
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2018-12-31 was 15.00K shares.
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2019 was 19.08K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2019-09-30 | 952.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | 2.83K shares derived: sum of 2 quarters · filed 2020-12-23 | 4.08K shares derived: sum of 3 quarters · filed 2020-12-23 | 19.08K shares 10-K · filed 2020-12-23 |
| 2019-06-30 | 1.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | 3.13K shares derived: sum of 2 quarters · filed 2019-08-14 | 18.13K shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 1.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | 16.25K shares 10-Q · filed 2019-05-15 | ||
| 2018-12-31 | 15.00K shares 10-Q · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |